Korro Bio (KRRO) Equity Average (2019 - 2025)
Historic Equity Average for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $107.1 million.
- Korro Bio's Equity Average fell 4330.69% to $107.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.1 million, marking a year-over-year decrease of 4330.69%. This contributed to the annual value of $165.2 million for FY2024, which is 36603.56% up from last year.
- According to the latest figures from Q3 2025, Korro Bio's Equity Average is $107.1 million, which was down 4330.69% from $127.0 million recorded in Q2 2025.
- In the past 5 years, Korro Bio's Equity Average ranged from a high of $188.9 million in Q3 2024 and a low of -$22.9 million during Q1 2023
- In the last 5 years, Korro Bio's Equity Average had a median value of $127.0 million in 2025 and averaged $116.2 million.
- The largest annual percentage gain for Korro Bio's Equity Average in the last 5 years was 131144.33% (2023), contrasted with its biggest fall of 11880.21% (2023).
- Over the past 5 years, Korro Bio's Equity Average (Quarter) stood at $139.0 million in 2021, then tumbled by 106.14% to -$8.5 million in 2022, then skyrocketed by 1311.44% to $103.3 million in 2023, then surged by 64.55% to $170.0 million in 2024, then plummeted by 37.03% to $107.1 million in 2025.
- Its Equity Average was $107.1 million in Q3 2025, compared to $127.0 million in Q2 2025 and $149.7 million in Q1 2025.